Phoenixville Hospital Medical Staff honors retirees with over 20 years of service dailylocal.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailylocal.com Daily Mail and Mail on Sunday newspapers.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Strongbridge Biopharma plc Announces Publication of Diabetes Subgroup Analysis from Phase 3 .
Strongbridge Biopharma plcApril 7, 2021 GMT
RECORLEV® (levoketoconazole) Treatment Demonstrates Clinically Meaningful Improvements in Cortisol Control and Clinical Benefit in Patients with Cushing’s Syndrome and Comorbid Diabetes Mellitus
DUBLIN, Ireland and TREVOSE, Pa., April 07, 2021 (GLOBE NEWSWIRE) Strongbridge Biopharma plc, (Nasdaq: SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that results from a subanalysis of patients with diabetes mellitus from the Phase 3 SONICS study of RECORLEV